Symmetry Partners LLC Buys New Holdings in Amdocs Limited (NASDAQ:DOX)

Symmetry Partners LLC bought a new stake in Amdocs Limited (NASDAQ:DOX) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 3,138 shares of the technology company’s stock, valued at approximately $284,000.

Several other hedge funds have also bought and sold shares of the company. Pzena Investment Management LLC increased its holdings in shares of Amdocs by 4.8% during the fourth quarter. Pzena Investment Management LLC now owns 4,239,513 shares of the technology company’s stock worth $372,611,000 after purchasing an additional 195,626 shares during the period. Invesco Ltd. increased its holdings in shares of Amdocs by 31.0% during the third quarter. Invesco Ltd. now owns 2,629,346 shares of the technology company’s stock worth $222,153,000 after purchasing an additional 621,962 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of Amdocs by 5.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,007,777 shares of the technology company’s stock worth $176,464,000 after purchasing an additional 94,856 shares during the period. American Century Companies Inc. increased its holdings in shares of Amdocs by 6.2% during the third quarter. American Century Companies Inc. now owns 1,980,219 shares of the technology company’s stock worth $167,309,000 after purchasing an additional 115,744 shares during the period. Finally, Vanguard Group Inc. boosted its position in shares of Amdocs by 1.4% during the 4th quarter. Vanguard Group Inc. now owns 1,457,368 shares of the technology company’s stock worth $128,088,000 after acquiring an additional 20,283 shares in the last quarter. 92.02% of the stock is currently owned by institutional investors and hedge funds.

Amdocs Stock Up 0.4 %

Amdocs stock traded up $0.34 during midday trading on Tuesday, hitting $76.35. 846,051 shares of the stock were exchanged, compared to its average volume of 711,847. The business’s 50-day moving average price is $82.01 and its 200-day moving average price is $87.13. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 52-week low of $74.41 and a 52-week high of $99.75. The stock has a market capitalization of $8.97 billion, a price-to-earnings ratio of 17.08, a price-to-earnings-growth ratio of 1.32 and a beta of 0.74.

Amdocs (NASDAQ:DOX) last released its quarterly earnings data on Wednesday, May 8th. The technology company reported $1.38 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.05). The business had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.25 billion. Amdocs had a return on equity of 17.85% and a net margin of 10.62%. On average, research analysts expect that Amdocs Limited will post 5.72 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.479 dividend. This represents a $1.92 annualized dividend and a yield of 2.51%. The ex-dividend date is Friday, June 28th. Amdocs’s payout ratio is 43.15%.

Analysts Set New Price Targets

Several research firms recently issued reports on DOX. Citigroup reduced their price target on shares of Amdocs from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Thursday, May 9th. Robert W. Baird cut their target price on shares of Amdocs from $97.00 to $90.00 and set a “neutral” rating on the stock in a research report on Thursday, May 9th. Finally, StockNews.com lowered shares of Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Amdocs presently has a consensus rating of “Moderate Buy” and a consensus price target of $103.80.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.